Genotyping Human Arylamine N-Acetyltransferase Type 1 (NAT1): The Identification of Two Novel Allelic Variants
- 1 February 1998
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 55 (3) , 361-366
- https://doi.org/10.1016/s0006-2952(97)00478-4
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumoursCytogenetic and Genome Research, 1997
- Arylamine N‐Acetyltransferase in Erythrocytes of Cystic Fibrosis PatientsBasic & Clinical Pharmacology & Toxicology, 1996
- A Prospective Study of Cigarette Smoking and Risk of Colorectal Adenoma and Colorectal Cancer in U.S. WomenJNCI Journal of the National Cancer Institute, 1994
- Carcinogen-DNA adducts in exfoliated urothelial cells: techniques for noninvasive human monitoring.Environmental Health Perspectives, 1993
- Human ArylamineN-Acetyltransferase Genes: Isolation, Chromosomal Localization, and Functional ExpressionDNA and Cell Biology, 1990
- Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.Journal of Clinical Investigation, 1990
- On the active site of liver acetyl-CoA. Arylamine N-acetyltransferase from rapid acetylator rabbits (III/J).Journal of Biological Chemistry, 1988
- Occupational Urothelial CancerBritish Journal of Urology, 1988
- Acetyltransferase in Humans: Development and Tissue DistributionPharmacology, 1986
- Multiple N-acetyltransferases and drug metabolism. Tissue distribution, characterization and significance of mammalian N-acetyltransferaseBiochemical Journal, 1973